SCHEMBL155154

SCHEMBL155154

COC(=O)[C@@H](N)C(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12035161 1.00
SCHEMBL254735 1.00
SCHEMBL9695112 1.00 SMN1; SMN2 (0.42)
SCHEMBL229160 1.00
SCHEMBL229159 1.00
SCHEMBL13748630 1.00
SCHEMBL155155 1.00
SCHEMBL9695108 1.00 SMN1; SMN2 (0.42)
SCHEMBL158741 1.00
SCHEMBL1912136 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119569652-A 2,2 '-Biquinoline-4, 4' -dicarboxylic acid aliphatic amino acid derivative, preparation and application thereof 武汉大学人民医院(湖北省人民医院) 2025-03-07 CN claimed
CN-119409587-A Amino acid derivative of 2,2 '-binaphthyl-6, 6' -dicarboxylic acid, and preparation method and application thereof 武汉大学人民医院(湖北省人民医院) 2025-02-11 CN claimed
CN-118619923-A Preparation method and application of tetrahydroisoquinoline PD-L1 inhibitor 大连理工大学 2024-09-10 CN claimed
CN-114315957-B Preparation method of polypeptide 深圳瑞德林生物技术有限公司 2023-07-07 CN claimed
CN-114315957-A Preparation method of polypeptide 深圳瑞德林生物技术有限公司 2022-04-12 CN claimed
CN-111647050-B Yi-lai-mycin F derivative and application thereof in preparation of mycobacterium tuberculosis resisting drugs 中国科学院南海海洋研究所 2021-11-09 CN claimed
CN-111647050-A Yi-lai-mycin F derivative and application thereof in preparation of mycobacterium tuberculosis resisting drugs 中国科学院南海海洋研究所 2020-09-11 CN claimed
EP-3087192-B1 METHOD OF PRODUCTION OF HUMAN INSULIN METHYL ESTER BIOCON BIOLOGICS INDIA LTD (IN) 2020-08-12 EP claimed
US-10611813-B2 Method of production of human insulin methyl ester BIOCON RESEARCH LIMITED (IN) 2020-04-07 US claimed
CN-105849273-B Process for the production of human insulin methyl ester 拜康研究有限公司 2020-01-14 CN claimed
US-20170002052-A1 Method of Production of Human Insulin Methyl Ester BIOCON BIOLOGICS INDIA LIMITED (IN) 2017-01-05 US claimed
EP-3087192-A1 METHOD OF PRODUCTION OF HUMAN INSULIN METHYL ESTER Biocon Research Limited (IN) 2016-11-02 EP claimed
WO-2015097643-A1 METHOD OF PRODUCTION OF HUMAN INSULIN METHYL ESTER BIOCON RESEARCH LIMITED (IN) 2015-07-02 WO claimed
EP-0085083-B1 PROCESS FOR THE ENZYMATIC PREPARATION OF HUMAN INSULIN NORDISK INSULINLABORATORIUM (DK) 1985-01-23 EP claimed
WO-1984003107-A1 A PROCESS FOR THE PREPARATION OF HUMAN INSULIN NORDISK INSULINLAB (DK) 1984-08-16 WO claimed
EP-0085083-A1 Process for the enzymatic preparation of human insulin. NORDISK INSULINLAB (DK) 1983-08-10 EP claimed
WO-1983000504-A1 ENZYMATIC PREPARATION OF HUMAN INSULIN ANDRESEN, FINN, HEDE 1983-02-17 WO claimed
CN-119409587-B Amino acid derivative of 2,2 '-binaphthyl-6, 6' -dicarboxylic acid, and preparation method and application thereof Renmin Hospital Of Wuhan University (hubei General Hospital) (CN) 2026-05-26 CN disclosed
EP-0045187-A1 A process for enzymatic replacement of the B-30 amino acid in insulins DE FORENEDE BRYGGERIER A/S (DK) 1982-02-03 EP disclosed
US-4273704-A N-Adamantane-substituted tetrapeptide amides G. D. SEARLE & CO. (US) 1981-06-16 US disclosed